Health Research Institute of the Balearic Islands (IdISBa)
Information
If you are the contact person for this centre and you wish to make any changes, please contact us.
SMC participants
Researcher at the Endocrinology and Nutrition Service, Vascular and Metabolic Diseases Research Group, Hospital Universitario Son Llàtzer, Instituto de Investigación Sanitaria de las Islas Baleares (IdISBa)
Contents related to this centre
In mice, administering semaglutide - the molecule marketed under the name Ozempic or Wegovy - does not reduce muscle mass as much as expected, but it does affect muscle function, according to a study published in Cell Metabolism. In some types of muscle, the experiment measured a decrease in force-generating capacity of about 20%, disproportionately greater than the loss of muscle mass.